Ann: NTCELL Parkinsons trial 2 year data analysis shows success, page-25

Masters of understatement and lacklustre announcements they are. But credit where it's due, they have found the only treatment in the world that stops PD in it's tracks, not bad after all. I'd be surprised if they can't find a backer with deep pockets to see this into the next stage. $19 mil. Is small beer to big pharma, danger for us shareholders is that they might want to buy the whole company at this low SP and we miss out on the big gains. For PD sufferers though it does not matter, the main thing is to get things moving and fast!